Page last updated: 2024-08-24

ruthenium chloride (rucl3) and allopurinol

ruthenium chloride (rucl3) has been researched along with allopurinol in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Batista, AA; Caldeira, RP; Correa, RS; da Silva, PFF; de Silveira-Lacerda, EP; Martins-Oliveira, A; Mello-Andrade, F; Pires, WC; Teixeira, T; Travassos, IO1

Other Studies

1 other study(ies) available for ruthenium chloride (rucl3) and allopurinol

ArticleYear
Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets.
    Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2021, Volume: 26, Issue:4

    Topics: Allopurinol; Animals; Antineoplastic Agents; Ascitic Fluid; Cell Cycle; Cell Migration Assays; Cell Survival; Cells, Cultured; Female; Fibroblasts; Humans; Mammary Neoplasms, Animal; Mice; Neoplasms, Experimental; Ruthenium Compounds

2021